Pharmaceutical Executive October 8, 2025
Shauna Tetrald, PhD, Director of Product Marketing at Quanterix, discussed translating complex scientific findings into actionable insights for healthcare providers and stakeholders, emphasizing the importance of early disease detection.
PE: The recent JAMA study highlights the association between biomarkers like p-tau181, NfL, and GFAP and early cognitive decline. From a product marketing perspective, how do you approach translating complex scientific findings like these into actionable insights for healthcare providers and stakeholders?
Tetrault: Yes, I think it’s important when a study like the JAMA study on subjective cognitive decline comes out to be able to translate it in such a way that it makes sense for a general audience as well as clinicians, right? And the significance of this study was interesting...







